We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+11.3%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$52.3B
AUM Growth
+$4.34B
(+9%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IS
ironSource Ltd.
IS
|
+$136M |
| 2 |
Tesla
TSLA
|
+$119M |
| 3 |
Verizon
VZ
|
+$109M |
| 4 |
Home Depot
HD
|
+$101M |
| 5 |
Pfizer
PFE
|
+$88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$247M |
| 2 |
Intel
INTC
|
+$216M |
| 3 |
Ford
F
|
+$145M |
| 4 |
General Motors
GM
|
+$143M |
| 5 |
Micron Technology
MU
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 14.97% |
| 3 | Financials | 14.22% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Axsome Therapeutics
AXSM
$12.1B
| $428K | ﹤0.01% |
+11,320
| New | +$417K |
|
|
RIDE
1677
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $424K | ﹤0.01% |
+8,199
| New | +$595K |
|
|
AGNT
1678
AGNT Inc
AGNT
$661M
| $423K | ﹤0.01% |
+12,570
| New | +$518K |
|
1679
First Bancorp
FBNC
$2.66B
| $422K | ﹤0.01% |
9,220
-4,180
| -31% | -$196K |
|
1680
Warrior Met Coal
HCC
$4.17B
| $420K | ﹤0.01% |
16,350
-3,350
| -17% | -$80.6K |
|
|
SPTN
1681
DELISTED
SpartanNash
SPTN
| $420K | ﹤0.01% |
16,315
-35,070
| -68% | -$846K |
|
|
DEA
1682
Easterly Government Properties
DEA
$1.17B
| $419K | ﹤0.01% |
7,316
-36,124
| -83% | -$1.95M |
|
|
DVAX
1683
DELISTED
Dynavax Technologies
DVAX
| $419K | ﹤0.01% |
+29,750
| New | +$490K |
|
|
LTC
1684
LTC Properties
LTC
$2.14B
| $418K | ﹤0.01% |
12,234
-30,430
| -71% | -$1.02M |
|
1685
Quince Therapeutics
QNCX
$18.9M
| $417K | ﹤0.01% |
+165
| New | +$1.01M |
|
|
QVCGA
1686
DELISTED
QVC Group Inc Series A
QVCGA
| $417K | ﹤0.01% |
1,099
+66
| +6% | +$29.8K |
|
|
WW
1687
DELISTED
WW International
WW
| $416K | ﹤0.01% |
25,800
-27,300
| -51% | -$490K |
|
1688
Rivian
RIVN
$24.2B
| $415K | ﹤0.01% |
+4,005
| New | +$461K |
|
1689
Celldex Therapeutics
CLDX
$2.79B
| $414K | ﹤0.01% |
+10,710
| New | +$467K |
|
|
SRNE
1690
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $414K | ﹤0.01% |
+88,990
| New | +$552K |
|
1691
AngioDynamics
ANGO
$593M
| $413K | ﹤0.01% |
14,960
-940
| -6% | -$25.9K |
|
1692
Genesco
GCO
$432M
| $411K | ﹤0.01% |
6,401
-12,030
| -65% | -$764K |
|
1693
Albertsons Companies
ACI
$5.67B
| $409K | ﹤0.01% |
13,538
-6,367
| -32% | -$202K |
|
1694
Array Technologies
ARRY
$785M
| $408K | ﹤0.01% |
+26,030
| New | +$509K |
|
|
TVTY
1695
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $407K | ﹤0.01% |
15,390
-17,210
| -53% | -$438K |
|
1696
Usana Health Sciences
USNA
$429M
| $405K | ﹤0.01% |
4,000
-7,700
| -66% | -$768K |
|
1697
The Joint Corp
JYNT
$123M
| $404K | ﹤0.01% |
6,150
-6,450
| -51% | -$520K |
|
1698
X4 Pharmaceuticals
XFOR
$371M
| $404K | ﹤0.01% |
5,884
+4,931
| +517% | +$624K |
|
1699
Park National Corp
PRK
$3.75B
| $401K | ﹤0.01% |
2,920
-3,180
| -52% | -$423K |
|
1700
Agios Pharmaceuticals
AGIO
$2.14B
| $400K | ﹤0.01% |
+12,180
| New | +$490K |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Ensign Peak Advisors held 2,277 positions worth $52.3B, up 9% from $48B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ensign Peak Advisors's Q4 2021 filing shows 427 new, 521 increased, 1,052 reduced and 79 closed positions. Its largest new stake was ironSource Ltd.: 13,801,563 shares worth $107M. The largest sale was AT&T, an estimated $247M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q4 2021 buy was ironSource Ltd.: 13,801,563 shares worth $107M.
- Ensign Peak Advisors added most to Tesla in Q4 2021, an estimated $119M increase.
- Ensign Peak Advisors's biggest Q4 2021 reduction was AT&T, cutting an estimated $247M.
- Ensign Peak Advisors fully exited Acceleron Pharma in Q4 2021, selling an estimated $21.5M.
- Ensign Peak Advisors's ten largest holdings make up 26% of its $52.3B portfolio in Q4 2021.
- Ensign Peak Advisors opened 427 new positions and closed 79 in Q4 2021.
- Ensign Peak Advisors's portfolio value rose 9% quarter-over-quarter to $52.3B.
Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.